Axcella Health Inc (NASDAQ:AXLA) People
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| David R. Epstein Other companies: AgomAb Therapeutics NV (Chairman of the Board · Since at least Mar 18, 2026); Tempus AI, Inc. (Director · Since at least Jun 13, 2024); Pfizer, Inc. (Director · Apr 13, 2026 – Nov 5, 2026 · Past); Seagen Inc (CEO, Director · Nov 9, 2022 – Dec 14, 2023 · Past); OPY Acquisition I Corp (Director · Oct 26, 2021 – Oct 26, 2021 · Past); Senti Biosciences Holdings, Inc. (Director · May 25, 2021 – Jul 13, 2022 · Past); Rubius Therapeutics Inc (Director · Jul 17, 2018 – May 12, 2022 · Past); Evelo Biosciences, Inc. (Director · May 8, 2018 – Jun 30, 2022 · Past); International Flavors & Fragrances, Inc. (Director · Jan 1, 2016 – Nov 2, 2020 · Past) | Director · May 8, 2019 – May 19, 2022 · Past |
| Paul Sekhri Other companies: Apnimed, Inc. (Director · Since at least Jul 30, 2026); vTv Therapeutics Inc. (Chairman of the Board, President and Chief Executive Officer · Since at least Aug 1, 2022); Veeva Systems Inc. (Director · Since at least Jun 22, 2016); Longboard Pharmaceuticals Inc (Director · Mar 11, 2021 – Dec 2, 2024 · Past); BiomX Inc. (Director · Oct 2, 2020 – Jul 28, 2021 · Past); Enumeral Biomedical Holdings Inc (Director · Dec 9, 2016 – Dec 9, 2016 · Past); Alpine Immune Sciences Inc (Director · Sep 12, 2016 – Jan 2, 2020 · Past) | Director · May 19, 2022 – May 19, 2022 · Past |
| Catherine Angell Sohn Other companies: Maze Therapeutics, Inc. (Director · Since at least Jan 30, 2025); Altimmune, Inc. (Director · Since at least Mar 23, 2023); Rubius Therapeutics Inc (Director · Jul 17, 2018 – May 12, 2022 · Past); Palisade Bio, Inc. (Director · Jan 13, 2014 – Jul 1, 2015 · Past); Lifecore Biomedical, Inc. (Director · Nov 13, 2012 – Jun 4, 2022 · Past); Jazz Pharmaceuticals plc (Director · Jul 27, 2012 – Aug 11, 2023 · Past) | Director · Aug 21, 2019 – May 19, 2022 · Past |
| David Berry Other companies: Averin Capital Acquisition Corp. (See Remarks, Director · Since at least Feb 18, 2026); Oaktree Acquisition Corp. III Life Sciences (Director · Since at least Oct 17, 2025); Omega Therapeutics Inc (Director · Jul 29, 2021 – Aug 3, 2021 · Past); Eleven Biotherapeutics Inc (Director · Feb 5, 2014 – Jun 8, 2016 · Past); Fortune Industries Inc (Director · May 18, 2007 – Mar 19, 2013 · Past) | Director · May 8, 2019 – May 20, 2020 · Past |
| Robert L Rosiello Other companies: Seres Therapeutics, Inc. (Director · Since at least Aug 5, 2025); Sana Biotechnology, Inc. (Director · Since at least Jun 5, 2025); Omega Therapeutics Inc (Director · Oct 2, 2024 – Oct 2, 2024 · Past); Evelo Biosciences, Inc. (Director · Apr 14, 2023 – Jun 8, 2023 · Past); Bausch Health Companies Inc. (EVP, Corp Dev & Strategy · Jun 11, 2015 – Dec 5, 2016 · Past) | Director · Oct 10, 2022 – Nov 16, 2022 · Past |
| Michael Rosenblatt Other companies: Azenta, Inc. (Director · Sep 4, 2018 – Feb 12, 2024 · Past); Rubius Therapeutics Inc (Director · Jul 17, 2018 – May 12, 2022 · Past); Merck & Company, Inc. (Exec V-P & Chief Med Officer · Dec 16, 2009 – May 10, 2016 · Past) | Director · May 19, 2022 – May 19, 2022 · Past |
| Thomas Leggett Other companies: Stoke Therapeutics, Inc. (Chief Financial Officer · Since at least May 7, 2024); Research Alliance Corp II (Director · Mar 17, 2021 – Mar 17, 2021 · Past); Black Diamond Therapeutics, Inc. (Chief Financial Officer · Jan 29, 2020 – Feb 17, 2021 · Past) | SVP Finance, CFO · May 8, 2019 – May 8, 2019 · Past |
| William D Baird III Other companies: 2Seventy Bio Inc (President and CEO, Director · Oct 18, 2021 – May 13, 2025 · Past); Bluebird bio Inc (Chief Financial Officer · Feb 11, 2019 – Nov 11, 2021 · Past); Amicus Therapeutics Inc (Chief Financial Officer · Apr 16, 2012 – Oct 15, 2018 · Past) | Director · May 8, 2019 – May 19, 2022 · Past |
| Christopher A. Viehbacher Other companies: Braveheart Bio, Inc. (Director · Since at least Aug 5, 2026); Biogen Inc. (President and Chief Executive Officer · Since at least Nov 14, 2022) | Director · May 8, 2019 – May 8, 2019 · Past |
| Gary P Pisano Other companies: Patheon N.V. (Director · Jul 20, 2016 – Aug 29, 2017 · Past); Sio Gene Therapies Inc (Director · May 13, 2016 – Apr 28, 2017 · Past) | Director · May 8, 2019 – May 19, 2022 · Past |
| Gregory Behar Other companies: Aimmune Therapeutics Inc (Director · Nov 23, 2016 – Oct 13, 2020 · Past); Seres Therapeutics, Inc. (Director · Jun 25, 2015 – Jun 22, 2023 · Past) | Director · May 8, 2019 – May 20, 2021 · Past |
| Heidy King-Jones Other companies: Spyre Therapeutics, Inc. (Chief Legal Officer and Corporate Secretary · Since at least Sep 1, 2023); Provention Bio Inc (Chief Legal Officer · Aug 3, 2020 – Apr 27, 2023 · Past) | General Counsel, SVP Legal · Nov 13, 2019 – Dec 18, 2019 · Past |
| Laurent Chardonnet Other companies: Prelude Therapeutics Incorporated (Chief Financial Officer · Nov 29, 2021 – Mar 1, 2024 · Past); Incyte Corporation (VP Finance and Treasurer · Jan 13, 2006 – Jan 13, 2006 · Past) | Chief Financial Officer · Nov 25, 2019 – Feb 9, 2021 · Past |
| Margaret Koziel Other companies: Innoviva, Inc. (Chief Medical Officer · Jul 31, 2023 – Jul 31, 2023 · Past) | Chief Medical Officer · Dec 1, 2021 – Mar 1, 2023 · Past |
| Martin Hendrix Other companies: Prometheus Biosciences Inc (Director · Mar 11, 2021 – Jun 16, 2023 · Past) | Director · May 19, 2022 – May 19, 2022 · Past |
| Shane Maltbie Other companies: Hillevax Inc (Chief Financial Officer · Since at least Jan 6, 2023) | See Remarks · Aug 21, 2019 – Aug 21, 2019 · Past |
| Shreeram Aradhye Other companies: Dicerna Pharmaceuticals Inc (EVP & Chief Medical Officer · Sep 8, 2020 – Dec 28, 2021 · Past) | Director · May 22, 2019 – May 20, 2021 · Past |
| Stephen Hoge Other companies: Moderna, Inc. (President · Since at least Dec 7, 2018) | Director · May 8, 2019 – May 20, 2021 · Past |
| Stephen Mitchener Other companies: Karyopharm Therapeutics Inc. (SVP, Chief Business Officer · Dec 31, 2020 – Feb 28, 2023 · Past) | SVP & Chief Business Officer · May 8, 2019 – Dec 18, 2019 · Past |
| Torben Straight Nissen Other companies: Rubius Therapeutics Inc (President · Jul 17, 2018 – Jul 24, 2019 · Past) | Director · Oct 10, 2022 – Nov 16, 2022 · Past |
| Alison D Schecter | President - Research & Dev. · Mar 15, 2021 – Feb 8, 2022 · Past |
| CRISTINA Rondinone | Director · May 8, 2019 – May 19, 2022 · Past |
| Manu Chakravarthy | SVP & Chief Medical Officer · May 8, 2019 – Feb 9, 2021 · Past |
| Paul Fehlner | SVP & Chief Legal Officer · May 8, 2019 – Feb 17, 2023 · Past |
| Robert Crane | Chief Financial Officer · Feb 8, 2022 – Mar 16, 2022 · Past |
| Tony Tramontin | SVP & Chief Scientific Officer · May 8, 2019 – Dec 18, 2019 · Past |
| Virginia R Dean | SVP, Chief People Officer · Jun 21, 2021 – Feb 8, 2022 · Past |
| William Hinshaw | President & CEO, Director · Sep 29, 2020 – Feb 17, 2023 · Past |